| Naomi Heights Nursing & Rehabilitation Center | |
| 2421 E. Texas Avenue, Alexandria, Louisiana 71301 | |
| (318) 443-5638 | |
| Name | Naomi Heights Nursing & Rehabilitation Center |
|---|---|
| Location | 2421 E. Texas Avenue, Alexandria, Louisiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 139 |
| Occupancy Rate | 55.4% |
| Medicare ID (CCN) | 195420 |
| Legal Business Name | Naomi Heights Nursing & Rehabilitation Center, Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1427030790 |
| Organization Name | NAOMI HEIGHTS NURSING & REHABILITATION CENTER, LLC |
| Doing Business As | NAOMI HEIGHTS NURSING & REHABILITATION CENTER |
| Address | 2421 E Texas Ave, Alexandria, LA 71301 |
| Phone Number | 318-443-5638 |
News Archive
A team led by a Los Angeles Biomedical Research Institute researcher developed a novel approach to efficiently identify disease relevant genes in human complex neurological disorders and demonstrated the effectiveness of this method by applying it to Amyotrophic Lateral Sclerosis, or Lou Gehrig's Disease, according to a new study reported online in the journal, Human Molecular Genetics.
The health care reform discussion is beginning-at last!-to get real. On June 9, the Senate Health, Education, Labor, and Pensions Committee released a draft bill, and the Congressional Budget Office published an estimate that the bill would cost $1 trillion over 10 years and leave 35 million uninsured.
Critical Path Institute (C-Path) announced today that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) from the U.S. Food and Drug Administration (FDA) issued a positive response to the Qualification Plan (QP) for glutamate dehydrogenase (GLDH) as a safety biomarker for drug-induced liver injury (DILI), developed by C-Path's Predictive Safety Testing Consortium (PSTC) and Duchenne Regulatory Science Consortium (D-RSC).
Today's headlines cover a range of topics related to the newly passed health overhaul bill, from the surrounding opposition and next steps to some of its policy implications.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A team led by a Los Angeles Biomedical Research Institute researcher developed a novel approach to efficiently identify disease relevant genes in human complex neurological disorders and demonstrated the effectiveness of this method by applying it to Amyotrophic Lateral Sclerosis, or Lou Gehrig's Disease, according to a new study reported online in the journal, Human Molecular Genetics.
The health care reform discussion is beginning-at last!-to get real. On June 9, the Senate Health, Education, Labor, and Pensions Committee released a draft bill, and the Congressional Budget Office published an estimate that the bill would cost $1 trillion over 10 years and leave 35 million uninsured.
Critical Path Institute (C-Path) announced today that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) from the U.S. Food and Drug Administration (FDA) issued a positive response to the Qualification Plan (QP) for glutamate dehydrogenase (GLDH) as a safety biomarker for drug-induced liver injury (DILI), developed by C-Path's Predictive Safety Testing Consortium (PSTC) and Duchenne Regulatory Science Consortium (D-RSC).
Today's headlines cover a range of topics related to the newly passed health overhaul bill, from the surrounding opposition and next steps to some of its policy implications.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 29.33 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.51 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 28.3 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.6 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.3 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.01 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.99 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 16.18 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 99.15 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 25.03 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 37.7 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.53 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 89.05 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 95.83 | 82.93 |
News Archive
A team led by a Los Angeles Biomedical Research Institute researcher developed a novel approach to efficiently identify disease relevant genes in human complex neurological disorders and demonstrated the effectiveness of this method by applying it to Amyotrophic Lateral Sclerosis, or Lou Gehrig's Disease, according to a new study reported online in the journal, Human Molecular Genetics.
The health care reform discussion is beginning-at last!-to get real. On June 9, the Senate Health, Education, Labor, and Pensions Committee released a draft bill, and the Congressional Budget Office published an estimate that the bill would cost $1 trillion over 10 years and leave 35 million uninsured.
Critical Path Institute (C-Path) announced today that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and Research (CDER) from the U.S. Food and Drug Administration (FDA) issued a positive response to the Qualification Plan (QP) for glutamate dehydrogenase (GLDH) as a safety biomarker for drug-induced liver injury (DILI), developed by C-Path's Predictive Safety Testing Consortium (PSTC) and Duchenne Regulatory Science Consortium (D-RSC).
Today's headlines cover a range of topics related to the newly passed health overhaul bill, from the surrounding opposition and next steps to some of its policy implications.
› Verified 3 days ago
Naomi Heights Nursing & Rehabilitation Center Location: 2421 E. Texas Avenue, Alexandria, Louisiana 71301 Phone: (318) 443-5638 | |
Matthews Memorial Health Care Center Location: 5100 Jackson Street Ext., Alexandria, Louisiana 71303 Phone: (318) 445-5215 | |
Regency House Of Alexandria Location: 5131 Masonic Drive, Alexandria, Louisiana 71301 Phone: (318) 445-8343 |